Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DQY14Z
|
|||
| Drug Name |
CSL 112
|
|||
| Drug Type |
Recombinant?protein
|
|||
| Indication | Acute myocardial infarction [ICD-11: BA41] | Phase 2 | [1] | |
| Company |
CSL Behring
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02108262) A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.